Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, dosage and administration, and formulary considerations of tiotropium are discussed. Conclusion ...

Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO.

Recently, tiotropium has been studied in asthma ... by a positive response to the nonspecific bronchial challenge test. Cholinergic drugs (acetylcholine and methacholine) are usually used for ...

Medicare Part D covers prescription drugs like Stiolto Respimat. The cost may vary, but the company that makes the medication has agreed to a cap of $35. Learn more here.

Stiolto Respimat (tiotropium bromide/olodaterol) is an inhaled medication for the treatment of chronic obstructive pulmonary disease (COPD), bronchitis, and emphysema. It’s not indicated as a ...

other medicines used regularly to treat your breathing problems that contain glycopyrronium, formoterol or other bronchodilators (such as ipratropium, tiotropium, aclidinium, umeclidinium ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

The drug is for moderate to severe acute pain. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe ...

A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET YOUR PRESCRIPTION MEDICATIONS. YEAH. SO UNDER THIS PLAN, MEXICO AND CANADA ...

Gary W. Miller receives funding from the National Institutes of Health, the Advanced Research Project Agency for Health, the Department of Defense, Cancer Research UK, and the European Commission.

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...